Trial To Focus on Botox Use for Treatment of Cerebral Pasly in Children

The Los Angeles Times carries this article: Orange County trial will focus on Botox's safety in children's cerebral palsy treatments, detailing a lawsuit filed against Allergan Inc. maker of Botox for alleged overdose of a girl being treated with the injections.

According to the article,

"Approved in the United States specifically to treat frown lines, crossed eyes and other conditions, Botox yields $1.3 billion in annual sales. But the drug can be legally prescribed at doctors' discretion for a variety of other purposes, including cerebral palsy. It is also specifically approved for cerebral palsy in many other countries. Its use for that condition alone contributed $47 million to Allergan's bottom line in 2007."

To read the full article, click on: Botox and Cerebral Palsy.

Another article can be found on DrugWatch.com, titled: Mother Blames Botox for Daughter’s Death, Manufacturer Faces First Lawsuit.